Drug Shortage Report for COTAZYM ECS 20

Last updated on 2020-03-30 History
Report ID 107554
Drug Identification Number 00821373
Brand name COTAZYM ECS 20
Common or Proper name PANCRELIPASE DELAYED-RELEASE CAPSULES
Company Name MERCK CANADA INC
Market Status MARKETED
Active Ingredient(s) AMYLASE PROTEASE LIPASE
Strength(s) 100000UNIT 100000UNIT 25000UNIT
Dosage form(s) CAPSULE (DELAYED RELEASE)
Route of administration ORAL
Packaging size 100CAP
ATC code A09AA
ATC description DIGESTIVES, INCL ENZYMES
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2020-04-03
Actual start date
Estimated end date 2020-04-10
Actual end date 2020-03-30
Shortage status Avoided shortage
Updated date 2020-03-30
Company comments
Health Canada comments
Contact Address 16750 ROUTE TRANSCANADIENNE
KIRKLAND, QUEBEC
CANADA H9H 4M7
Company contact information 1-800-567-2594 medinfocanada@merck.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2020-03-30 French Compare
v3 2020-03-30 English Compare
v2 2020-03-02 French Compare
v1 2020-03-02 English Compare